# ACM Research, Inc.: overview

ACMR · Nasdaq · CIK 1680062 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acmr.md) · [Financials](/companies/acmr/financials.md) · [Filings](/companies/acmr/filings.md) · [Insiders](/companies/acmr/insiders.md)

Latest reported revenue: [$292.9m](/filings/0001628280-26-054832.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054832).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [204](/filings/0001628280-25-050152.md) | [223 d](/filings/0001628280-26-013231.md) | [172](/filings/0001628280-26-032842.md) | [215](/filings/0001628280-26-054832.md) | [269](/filings/0001628280-25-050152.md) | [244 d](/filings/0001628280-26-013231.md) | [231](/filings/0001628280-26-032842.md) | [293](/filings/0001628280-26-054832.md) |
| Gross margin | % | [51.4%](/filings/0001628280-25-050152.md) | [49.6% d](/filings/0001628280-26-013231.md) | [47.9%](/filings/0001628280-26-032842.md) | [48.5%](/filings/0001628280-26-054832.md) | [42.0%](/filings/0001628280-25-050152.md) | [40.9% d](/filings/0001628280-26-013231.md) | [46.4%](/filings/0001628280-26-032842.md) | [46.0%](/filings/0001628280-26-054832.md) |
| Operating margin | % | [21.7%](/filings/0001628280-25-050152.md) | [19.7% d](/filings/0001628280-26-013231.md) | [15.0%](/filings/0001628280-26-032842.md) | [14.7%](/filings/0001628280-26-054832.md) | [10.7%](/filings/0001628280-25-050152.md) | [9.4% d](/filings/0001628280-26-013231.md) | [15.6%](/filings/0001628280-26-032842.md) | [17.0%](/filings/0001628280-26-054832.md) |
| Net margin | % | [15.2%](/filings/0001628280-25-050152.md) | [13.9% d](/filings/0001628280-26-013231.md) | [11.8%](/filings/0001628280-26-032842.md) | [13.8%](/filings/0001628280-26-054832.md) | [13.3%](/filings/0001628280-25-050152.md) | [3.3% d](/filings/0001628280-26-013231.md) | [7.5%](/filings/0001628280-26-032842.md) | [30.4%](/filings/0001628280-26-054832.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001628280-25-050152.md) | not reported | [0.30](/filings/0001628280-26-032842.md) | [0.44](/filings/0001628280-26-054832.md) | [0.52](/filings/0001628280-25-050152.md) | not reported | [0.24](/filings/0001628280-26-032842.md) | [1.23](/filings/0001628280-26-054832.md) |
| Free cash flow | $m | [(20.6) d](/filings/0001628280-25-050152.md) | [77.2 d](/filings/0001628280-26-013231.md) | [(11.4)](/filings/0001628280-26-032842.md) | [(59.6) d](/filings/0001628280-26-054832.md) | [(15.6) d](/filings/0001628280-25-050152.md) | [20.1 d](/filings/0001628280-26-013231.md) | [(51.7)](/filings/0001628280-26-032842.md) | [(71.5) d](/filings/0001628280-26-054832.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [260](/filings/0001680062-24-000008.md) | [389](/filings/0001680062-25-000003.md) | [558](/filings/0001628280-26-013231.md) | [782](/filings/0001628280-26-013231.md) | [901](/filings/0001628280-26-013231.md) |
| Gross margin | % | [44.2%](/filings/0001680062-24-000008.md) | [47.2%](/filings/0001680062-25-000003.md) | [49.5%](/filings/0001628280-26-013231.md) | [50.1%](/filings/0001628280-26-013231.md) | [44.4%](/filings/0001628280-26-013231.md) |
| Operating margin | % | [14.9%](/filings/0001680062-24-000008.md) | [15.2%](/filings/0001680062-25-000003.md) | [17.2%](/filings/0001628280-26-013231.md) | [19.3%](/filings/0001628280-26-013231.md) | [12.1%](/filings/0001628280-26-013231.md) |
| Net margin | % | [14.5%](/filings/0001680062-24-000008.md) | [10.1%](/filings/0001680062-25-000003.md) | [13.9%](/filings/0001628280-26-013231.md) | [13.2%](/filings/0001628280-26-013231.md) | [10.4%](/filings/0001628280-26-013231.md) |
| Diluted EPS | $ per share | [0.58](/filings/0001680062-24-000008.md) | [0.59](/filings/0001680062-25-000003.md) | [1.16](/filings/0001628280-26-013231.md) | [1.53](/filings/0001628280-26-013231.md) | [1.37](/filings/0001628280-26-013231.md) |
| Free cash flow | $m | [(49.2)](/filings/0001680062-24-000008.md) | [(153)](/filings/0001680062-25-000003.md) | [(137)](/filings/0001628280-26-013231.md) | [70.0](/filings/0001628280-26-013231.md) | [(66.6)](/filings/0001628280-26-013231.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/acmr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.10bn | 8,660,842 |  | Added +675,995 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $425.0m | 3,349,436 |  | Added +1,145,605 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $312.5m | 2,462,745 |  | Added +198,408 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $304.3m | 2,398,036 |  | New +2,398,036 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $277.7m | 2,188,254 |  | Added +182,138 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $188.8m | 1,487,797 |  | Added +116,570 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $156.9m | 1,236,800 | Call | Added +845,700 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $148.5m | 1,170,080 |  | Added +382,979 |
| [Value Aligned Research Advisors, LLC](/funds/1963565.md) | 2026-06-30 | $133.7m | 1,053,949 |  | Added +98,022 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $121.1m | 954,474 |  | Added +235,451 |

## Recent filings

[All 620 filings](/companies/acmr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 08:13 ET | [8-K](/filings/0001628280-26-067734.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067734 |
| 2026-09-30 | 08:06 ET | [8-K](/filings/0001628280-26-063896.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063896 |
| 2026-08-27 | 16:05 ET | [8-K](/filings/0001628280-26-059251.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-059251 |
| 2026-08-07 | 16:07 ET | [10-Q](/filings/0001628280-26-054832.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054832 |
| 2026-08-07 | 07:37 ET | [8-K](/filings/0001628280-26-054581.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054581 |
| 2026-06-22 | 09:11 ET | [8-K](/filings/0001628280-26-044506.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-044506 |
| 2026-06-12 | 16:06 ET | [8-K](/filings/0001628280-26-042833.md) | 5.07 Shareholder vote results | 0001628280-26-042833 |
| 2026-05-29 | 16:01 ET | [8-K](/filings/0001140361-26-023310.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-023310 |
| 2026-05-22 | 08:46 ET | [8-K](/filings/0001628280-26-037552.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-037552 |
| 2026-05-15 | 16:16 ET | [8-K](/filings/0001140361-26-021661.md) | 8.01 Other events | 0001140361-26-021661 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-013231.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/738284ff-b1b8-4c4a-a243-f49e0d20bfbe)

## About the filer

- CIK: 1680062
- Tickers: ACMR
- Exchange: Nasdaq
- SIC code: 3559 Special Industry Machinery, NEC
- State of incorporation: CA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 08:14 ET. No prices; not investment advice.